Lots of people have really strange ideas about what defamation entails. Far too many people believe defamation occurs anytime their feelings are hurt or they aren't portrayed in the best light possible. These people are wrong. Often, those in wrong choose to represent themselves when they desire to be out-tilted by windmills. Sometimes, they retain…
TravelCenters of America Establishes New Business Unit to Advance Sustainable Energy With the launch of eTA, the retailer aims to be at the forefront of important trends such as electrification and decarbonization.
WESTLAKE, Ohio TravelCenters of America Inc. (TA) is launching eTA, a new unit dedicated to partnering with the public sector, private companies and customers to deliver sustainable and alternative energy. As everyday travelers embrace the benefits of energy alternatives and the trucking industry continues its transition toward cleaner and more efficient fuels, TA is uniquely positioned to capitalize on this shift and the significant opportunities it creates, said Jon Pertchik, CEO of TA. Now is the optimal time to sharpen our focus on sustainability, particularly in light of the Biden Administration’s infrastructure plan.
Published: Apr 01, 2021
CULVER CITY, Calif. (BUSINESS WIRE) ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced the appointment of health innovation expert and executive Linda Maxwell, M.D., MBA, as an independent member of the company’s board of directors. The company also appointed CEO Richard Adcock to the board; he was named CEO of NantKwest in October and remains the CEO of the company after the merger of NantKwest with ImmunityBio in March. Both appointments are effective March 29, 2021.
The nine-member ImmunityBio board is led by Founder and Executive Chairman Patrick Soon-Shiong, M.D. The board includes two other recently appointed outside members, former CIA director John Brennan and retired U.S. Army General Wesley Clark, along with current board members Michael Blaszyk, Cheryl Cohen, Christobel Selecky, and Barry Simon, M.D.